We are live on
!
Find out more
GS
Gagnon Securities Portfolio holdings
AUM
$519M
1-Year Est. Return
44.91%
This Fund
S&P 500
This Quarter
Est. Return
+9.34%
1 Year Est. Return
+44.91%
3 Year Est. Return
+129.38%
5 Year Est. Return
+108.07%
10 Year Est. Return
+1,389.15%
AUM
$282M
AUM Growth
+$12.8M
(+4.8%)
Cap. Flow
+$1.45M
Cap. Flow
% of AUM
0.51%
Top 10 Holdings %
Top 10 Hldgs %
44.88%
Holding
102
New
7
Increased
30
Reduced
38
Closed
11
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FLXN
Flexion Therapeutics, Inc.
FLXN
|
+$4.76M |
| 2 |
GFNCP
General Finance Corporation Cumulative Redeemable Perpetual Preferred Series C
GFNCP
|
+$3.58M |
| 3 |
ATHN
Athenahealth, Inc.
ATHN
|
+$1.29M |
| 4 |
QuidelOrtho
QDEL
|
+$1.13M |
| 5 |
Enterprise Products Partners
EPD
|
+$928K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RTEC
Rudolph Technologies Inc
RTEC
|
+$2.81M |
| 2 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$2.51M |
| 3 |
CareDx
CDNA
|
+$1.79M |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.41M |
| 5 |
FIVE9
FIVN
|
+$955K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.17% |
| 2 | Industrials | 19.6% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 8.03% |
| 5 | Energy | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AT
76
DELISTED
Atlantic Power Corporation
AT
| $125K | 0.04% |
53,194
-1,548
| -3% | -$3.8K |
|
|
SRNE
77
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $112K | 0.04% |
29,568
-2,018
| -6% | -$5.26K |
|
78
TherapeuticsMD
TXMD
$24M
| $105K | 0.04% |
348
| – | – |
|
|
CBK
79
DELISTED
Christopher & Banks Corporation
CBK
| $78K | 0.03% |
61,651
-61,660
| -50% | -$78K |
|
|
HOS
80
DELISTED
Hornbeck Offshore Services, Inc.
HOS
| $49K | 0.02% |
15,765
| – | – |
|
|
BELFB
81
Bel Fuse Inc Class B
BELFB
$4.25B
| – | – |
-8,684
| Closed | -$271K |
|
82
Cameco
CCJ
$41.1B
| – | – |
-21,195
| Closed | -$205K |
|
|
FLNA
83
Filana Therapeutics
FLNA
$46.4M
| – | – |
-15,568
| Closed | -$63K |
|
|
TTNP
84
DELISTED
Titan Pharmaceuticals
TTNP
| – | – |
-10
| Closed | -$61K |
|
85
Vanda Pharmaceuticals
VNDA
$306M
| – | – |
-18,131
| Closed | -$325K |
|
86
Expro Ltd
XPRO
$1.83B
| – | – |
-2,673
| Closed | -$124K |
|
|
AIFU
87
AIFU Inc
AIFU
$216M
| – | – |
-103
| Closed | -$516K |
|
|
SRGA
88
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| – | – |
-2,114
| Closed | -$289K |
|
Similar funds
CI
WPP
CFM
LHC
AAM
RCI
SCM
SC
Gagnon Securities's Q4 2017 Portfolio in Review
As of Q4 2017, Gagnon Securities held 102 positions worth $282M, up 4.8% from $269M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Gagnon Securities's Q4 2017 filing shows 7 new, 30 increased, 38 reduced and 11 closed positions. Its largest new stake was General Finance Corporation Cumulative Redeemable Perpetual Preferred Series C: 35,792 shares worth $3.59M. The largest sale was Rudolph Technologies Inc, an estimated $2.81M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 30% a quarter earlier, followed by Industrials and Healthcare.
- Gagnon Securities's largest Q4 2017 buy was General Finance Corporation Cumulative Redeemable Perpetual Preferred Series C: 35,792 shares worth $3.59M.
- Gagnon Securities added most to Flexion Therapeutics, Inc. in Q4 2017, an estimated $4.76M increase.
- Gagnon Securities's biggest Q4 2017 reduction was Rudolph Technologies Inc, cutting an estimated $2.81M.
- Gagnon Securities fully exited AIFU Inc in Q4 2017, selling an estimated $516K.
- Gagnon Securities's ten largest holdings make up 45% of its $282M portfolio in Q4 2017.
- Gagnon Securities opened 7 new positions and closed 11 in Q4 2017.
- Gagnon Securities's portfolio value rose 4.8% quarter-over-quarter to $282M.
Based on Gagnon Securities's 13F filing for Q4 2017, filed 13 Feb 2018.